Oral contraceptive use and smoking habits in young Israeli women: A cross-sectional study

Israel Medical Association Journal

Volumn 6, Issue 9, 2004, Pages 546-549

  Zimlichman, Eyal ^a,b   Mandel, Dror ^a   Mimouni, Francis B ^a   Wartenfeld, Robert ^a   Huerta, Michael ^a   Grotto, Itamar ^a   Kreiss, Yitshak ^a  

^a MEDICAL CORPS   (Israel)

^b NONE   (Israel)

Author keywords

Cardiovasular risk; Obesity; Oral contraceptives; Smoking; Women's healht

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CONTROLLED STUDY; COUNSELING; DATA ANALYSIS; DISEASE ASSOCIATION; DRUG USE; EDUCATION; FAMILY HISTORY; FAMILY SIZE; FEMALE; HUMAN; INFORMATION PROCESSING; ISRAEL; OBESITY; ORAL CONTRACEPTION; QUESTIONNAIRE; RISK FACTOR; SMOKING HABIT; SOLDIER; STATISTICAL SIGNIFICANCE;

ADULT; BODY MASS INDEX; CONTRACEPTION BEHAVIOR; CONTRACEPTIVES, ORAL; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH BEHAVIOR; HUMANS; ISRAEL; LOGISTIC MODELS; RISK FACTORS; SMOKING;

EID: 4544281660     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Mann JI, Vessey MP, Thorogood M, Doll SR. Myocardial infarction in young women with special reference to oral contraceptive practice. Br Med J 1975;2:241-5.
2. Jick H, Dinan B, Herman R, Rothman KJ. Myocardial infarction and other vascular disease in young women: role of estrogens and other factors. JAMA 1978;240:2548-52.
3. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: Results of an international multicenter case-control study. Lancet 1995;346:1575-82.
4. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international multicenter case-control study. Lancet 1996;348:505-10.
5. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Acute myocardial infarction and combined oral contraceptives: results of an international multicenter case-control study. Lancet 1997;349:1202-9.
6. Mann JI, Inman WHW, Thorogood M. Oral contraceptive use in older women and fatal myocardial infarction. Br Med J 1976;2:445-7.
7. Fruzzetti F, Ricci C, Fioretti P. Haemostasis profile in smoking and nonsmoking women taking low-dose oral contraceptives. Contraception 1994;49:579-89.
8. Kark JD, Laor A. Cigarette smoking and educational level among young Israelis upon release from military service in 1988 - a public health challenge. Isr J Med Sci 1992;28:33-7.
9. Centraal Bureau voor Statistiek. Statistisch jaarboek 1998. The Hague: SDU/Uitgeverij, 1998:491.
10. Sargent JD, Beach ML, Dalton MA, et al. Effect of seeing tobacco use in films on trying smoking among adolescents: cross sectional study. Br Med J 2001;323:1-6.
11. Wechsler H, Rigotti NA, Gledhill-Hoyt J, Lee H. Increased levels of cigarette use among college students: a cause for national concern. JAMA 1998;280:1673-8.
12. Davis RM. Current trends in cigarette advertising and marketing. N Engl J Med 1987;316(12):725-32.
13. Sepe E, Glantz SA. Bar and tobacco promotions in the alternative press: targeting young adults. Am J Public Health 2002;92:75-8.
14. Aveyard P, Cheng KK, Almond J, et al. Cluster randomized clinical trial of expert system based on the transtheoretical (" stages of change") model for smoking prevention and cessation in schools. Br Med J 1999;319:948-53.
15. Coker AL, Richter DL, Valois RF, McKeown RE, Garrison CZ, Vincent ML. Correlates and consequences of early initiation of sexual intercourse. J Sch Health 1994;64:372-7.
16. Hogan RM. Influences of culture on sexuality. Nurs Clin North Am 1982;17:365-76.
17. Schenker JG. Women's reproductive health: monotheistic religious perspectives. Int J Gynaecol Obstet 2000;70:77-86.
18. Farley TMM, Meirik O, Poulter NR. Combined oral contraceptives, smoking, and cardiovascular risk. J Epidemiol Community Health 1998;52:775.
19. Rosenberg L, Palmer JR, Rao RS, Shapiro S. Low-dose oral contraception use and the risk of myocardial infarction. Arch Intern Med 2001;161:1065-70.
20. Mileikowsky GN, Nadler JL, Huey F, Francis R, Roy S. Evidence that smoking alters prostacyclin formation and platelet aggregation in women who use oral contraceptives. Obstet Gynecol 1988;159:1537-52.
21. Rangemark C, Benthin G, Granstrom EF, Persson L, Winell S, Wennmalm A. Tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in women stratified by age. Circulation 1992;86:1495-500.
22. Notelovitz M, Levenson I, McKenzie L, Khan FY. The effect of low-dose oral contraceptives on lipids and lipoproteins in two at-risk populations: young female smokers and older premenopausal women. Contraception 1991;44(5):505-16.
23. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001;344(16):1222-31.
24. Vandenbroucke JP, Koster T, Briet E, Reitsma PH, Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994;344:1453-7.
25. Bloemenkamp KWM, Rosendaal FR, Helmerhorst FM, Buller HR, Vandenbroucke JP. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet 1995;346:1593-6.